- TapImmune (TPIV -0.5%) wins its arbitration case against Michael Gardner of Bay Tree Capital. CEO Glynn Wilson, Ph.D., took exception to Mr. Gardner's lack of success in raising capital for the firm despite paying him 5.6M shares of the company's stock (9.9% stake). The arbitrator awards the company ~$196K plus interest.
TapImmune wins dispute with would-be consultant
Recommended For You
About MRKR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MRKR | - | - |
| Marker Therapeutics, Inc. | ||